Robert Balk to Risk Assessment
This is a "connection" page, showing publications Robert Balk has written about Risk Assessment.
Connection Strength
0.145
-
Ventilator Liberation for High-Risk-for-Failure Patients: Improving Value of the Spontaneous Breathing Trial. Respir Care. 2015 Feb; 60(2):290-6.
Score: 0.098
-
Procalcitonin as an Early Marker of the Need for Invasive Respiratory or Vasopressor Support in Adults With Community-Acquired Pneumonia. Chest. 2016 Oct; 150(4):819-828.
Score: 0.027
-
Multinational, observational study of procalcitonin in ICU patients with pneumonia requiring mechanical ventilation: a multicenter observational study. Crit Care. 2011; 15(2):R88.
Score: 0.019